Corporate philosophy
The dawn of new cancer treatments
According to the latest statistics, it is predicted that one in two Japanese people suffers from cancer in their lifetime. That is to say, cancer is not a special illness and anyone may suffer from cancer.
Therefore, International Cancer Laboratory is engaged in research and development of the most advanced technology to explore safe treatments that may suppress the proliferation of cancer and shrink the tumor.
The company incorporates the most advanced cancer treatment of the world to Japan at the same time to help pursuit happiness for as many cancer patients as possible.
Overview
| Company name | International Cancer Laboratory Co., Ltd. |
|---|---|
| Office address | 2nd Floor, No. 3 Toho Bldg., 1-6-8 Shintomi, Chuo-ku, Tokyo 104-0041 |
| Foundation date | 13 August, 2021 |
| Capital stock | 9,000,000 Yen |
| Description of business | １．Research and development of the prevention, examination, and treatment of cancer ２．Technical cooperation on the prevention, examination, and treatment of cancer ３．International cooperation on the prevention, examination, and treatment of cancer |
| CEO | Norio Takeuchi |
| Business associate | Imugene (Australia) Almac (UK) Neues (Japan) Seppic (France) |
| Bank accounts | Mizuho Bank, The Higashi-Nippon Bank, Rakuten Bank |